Former first-round pick Blake Brockermeyer, who scouts college players, has an early look at the best 2026 prospects.

This could actually make it somewhat easier to analyze than ... At the current share price, the company’s common stock yields 3.02%, which is higher than either the S&P 500 Index (SPY) or ...

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

Troy has spent the past two decades trying to figure out what to do with the dilapidated red-brick former mill complex; plans ...

We provide a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability ...

While in India on Tuesday, U.S. Vice President JD Vance called for enhanced engagement with the South Asian country. He said ...

From electronics to everyday essentials, here's what to prioritize in your shopping cart as trade tensions rise.

One thing I'm fairly certain of is that Palantir's stock will likely make a large move on the day following earnings; the question is whether that move will be up or down. For three of its four ...

The phase III ACHIEVE-1 study ... In response to LLY’s successful study data, NVO’s stock lost 7.6% in the last trading session. Oral medications, being more convenient than injectables ...

Drugmakers Roche and Regeneron said they will spend billions of dollars to expand U.S. manufacturing, the latest pharmaceutical companies to commit to American production as new and future tariffs ...

In addition to the consolidation of embassies and consulates, the order would make fundamental changes to the hiring practices at the department. The longstanding Foreign Service Officer Test ...